are b12 injections intramuscular Administering a Injection : 5 Steps Reel by @edupointmed (@edupointmed) ·

Pivotal trial result: AOD-9604's Phase 2b trial (536 subjects, 24 weeks) failed its primary endpoint

9.6 for placebo Patients in randomized clinical study Adverse events reported across all treatment groups AHK-Cu first shown to stimulate dermal papilla cell proliferation while inhibiting follicle apoptosis Lee WJ et al., Annals of Dermatology, 2016 (PMID: 27489425) Pickart L, J Biomater Sci, 2008 (PMID: 18644225) Shin HS et al., Archives of Pharmacal Research, 2007 (PMID: 17703734) The Formula Two Copper Peptides

PMID: 18413300 Noppakun N, Swasdikul D

Refrigerate reconstituted AOD-9604 at 2-8 degrees Celsius (35-46 degrees Fahrenheit)